Wuhan Easy Diagnosis Biomedicine Co Ltd Class A - Asset Resilience Ratio

Latest as of September 2025: 6.64%

Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (002932) has an Asset Resilience Ratio of 6.64% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Wuhan Easy Diagnosis Biomedicine Co Ltd balance sheet liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥404.92 Million

≈ $59.25 Million USD Cash + Short-term Investments

Total Assets

CN¥6.10 Billion

≈ $892.79 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2019–2024)

This chart shows how Wuhan Easy Diagnosis Biomedicine Co Ltd Class A's Asset Resilience Ratio has changed over time. See net assets of Wuhan Easy Diagnosis Biomedicine Co Ltd for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Wuhan Easy Diagnosis Biomedicine Co Ltd Class A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Wuhan Easy Diagnosis Biomedicine Co Ltd (002932) total market value.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥404.92 Million	6.64%
Total Liquid Assets	CN¥404.92 Million	6.64%

Asset Resilience Insights

Limited Liquidity: Wuhan Easy Diagnosis Biomedicine Co Ltd Class A maintains only 6.64% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Wuhan Easy Diagnosis Biomedicine Co Ltd Class A Industry Peers by Asset Resilience Ratio

Compare Wuhan Easy Diagnosis Biomedicine Co Ltd Class A's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
INKON Life Technology Co Ltd SHE:300143	Medical Devices	3.37%
CareRay Digital Medical Technology Co Ltd SHG:688607	Medical Devices	16.21%
Senseonics Holdings, Inc. Common Stock NYSE MKT:SENS	Medical Devices	54.67%
Universus Photo Imagings Limited NSE:UNIVPHOTO	Medical Devices	30.97%
HansBiomed Corporation KQ:042520	Medical Devices	9.13%
Aligned Genetics Inc KQ:238120	Medical Devices	2.22%
Heramed Ltd AU:HMD	Medical Devices	0.83%
Acarix A/S ST:ACARIX	Medical Devices	37.81%

Annual Asset Resilience Ratio for Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (2019–2024)

The table below shows the annual Asset Resilience Ratio data for Wuhan Easy Diagnosis Biomedicine Co Ltd Class A.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	0.97%	CN¥64.12 Million ≈ $9.38 Million	CN¥6.59 Billion ≈ $964.77 Million	-0.69pp
2023-12-31	1.66%	CN¥122.59 Million ≈ $17.94 Million	CN¥7.39 Billion ≈ $1.08 Billion	-19.59pp
2022-12-31	21.25%	CN¥1.95 Billion ≈ $285.75 Million	CN¥9.19 Billion ≈ $1.34 Billion	+0.76pp
2021-12-31	20.49%	CN¥700.00 Million ≈ $102.43 Million	CN¥3.42 Billion ≈ $500.03 Million	+6.47pp
2020-12-31	14.02%	CN¥200.00 Million ≈ $29.27 Million	CN¥1.43 Billion ≈ $208.76 Million	-17.31pp
2019-12-31	31.33%	CN¥200.00 Million ≈ $29.27 Million	CN¥638.42 Million ≈ $93.42 Million	--

pp = percentage points

About Wuhan Easy Diagnosis Biomedicine Co Ltd Class A

SHE:002932 China Medical Devices

Market Cap

$577.41 Million

CN¥3.95 Billion CNY

Market Cap Rank

#11805 Global

#3617 in China

Share Price

CN¥16.97

Change (1 day)

+0.41%

52-Week Range

CN¥15.90 - CN¥22.86

All Time High

CN¥49.58